| FDA notifications. Darunavir label has these changes. [Newspaper Article] AIDS Alert 2008 Dec; 23(12):142-4. Full Citation | Find Related Articles | | Wang L, Cai SR, Zhang CH, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. [Journal Article] Chin Med J (Engl) 2008 Nov 5; 121(21):2167-71. Abstract | Full Citation | Find Related Articles | | Gao L, Yu DM Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. [Journal Article] Chin Med J (Engl) 2008 Nov 5; 121(21):2129-33. Abstract | Full Citation | Find Related Articles | | Narayanan RM, Chi LS, Choo LL, et al. Renal outcomes in the ONTARGET study. [Comment, Letter] Lancet 2008 Dec 13; 372(9655):2020; author reply 2020-1. Full Citation | Publisher Full Text | Find Related Articles | | Wetzels JF Renal outcomes in the ONTARGET study. [Comment, Letter] Lancet 2008 Dec 13; 372(9655):2020; author reply 2020-1. Full Citation | Publisher Full Text | Find Related Articles | | Gallieni M, Cozzolino M, Brancaccio D, et al. Renal outcomes in the ONTARGET study. [Comment, Letter] Lancet 2008 Dec 13; 372(9655):2019; author reply 2020-1. Full Citation | Publisher Full Text | Find Related Articles | | Nonoguchi H, Nanami M, Hasuike Y, et al. Renal outcomes in the ONTARGET study. [Comment, Letter] Lancet 2008 Dec 13; 372(9655):2019-20; author reply 2020-1. Full Citation | Publisher Full Text | Find Related Articles | | Barrios V, Escobar C, Echarri R Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril. [Journal Article] Vasc Health Risk Manag 2008; 4(4):847-53. Abstract | Full Citation | | Richter B, Bandeira-Echtler E, Bergerhoff K, et al. Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes. [Journal Article] Vasc Health Risk Manag 2008; 4(4):753-68. Abstract | Full Citation | | Green J, Feinglos M New combination treatments in the management of diabetes: focus on sitagliptin-metformin. [Journal Article] Vasc Health Risk Manag 2008; 4(4):743-51. Abstract | Full Citation |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|